Carregant...
Association between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure with Reduced Ejection Fraction
OBJECTIVE: Our objective is to describe the short-term, health status benefits of ARNI initiation in patients with heart failure and reduced ejection fraction (HFrEF). BACKGROUND: While sacubitril/valsartan, a neprilysin inhibitor (ARNI), improved patients’ health status (compared with enalapril) at...
Guardat en:
| Publicat a: | JACC Heart Fail |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7122134/ https://ncbi.nlm.nih.gov/pubmed/31521679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2019.05.016 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|